ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Healy to Name Jay Moskowitz Deputy Direct, Promote Mahoney To Deputy Budge Director

March 6, 1992

Southwest Oncology Group Becomes “SWOG”

April 8, 2011

NCI Appropriations Still Hung Up

September 30, 1977

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

April 27, 2001

Tacoma Tests Of Two Patients Who Received Bahamas Treatment Are Positive For AIDS; Sera Contaminated

July 12, 1985

NTP Board Okays Three Cooperative Agreement Concepts, Including Corn Oil Carcinogens is Test

October 7, 1983